Consensus Ventas, Inc.

Equities

VTR

US92276F1003

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
50.26 USD +2.57% Intraday chart for Ventas, Inc. +5.81% +0.84%

Evolution of the average Target Price on Ventas, Inc.

Price target over the last 5 years

History of analyst recommendation changes

43a5cd385f79abad5e4d38cc.99Dsn034aVuXwpcqNJwWnGIswNZXNxDNLz7-_Iflf8k.wrWA1wrMIAriltRsUM4vylt_9YICe0O4bFmMhPGDSIzOvduuNJUiAdOyzg~37fc72f163b345dd2058c240b8acb2f2
Wells Fargo Adjusts Price Target on Ventas to $49 From $46 MT
JPMorgan Adjusts Price Target on Ventas to $50 From $48 MT
BMO Capital Adjusts Ventas Price Target to $53 From $51 MT
Scotiabank Adjusts Price Target on Ventas to $51 From $47 MT
Morgan Stanley Adjusts Price Target on Ventas to $49 From $47, Keeps Equalweight Rating MT
Ventas Insider Sold Shares Worth $697,653, According to a Recent SEC Filing MT
Jefferies Adjusts Price Target on Ventas to $56 From $52 MT
RBC Capital Adjusts Price Target on Ventas to $52 From $50 MT
ANALYST RECOMMENDATIONS : Nvidia, The Home Depot, Lowe's, Rollins... Our Logo
Evercore ISI Adjusts Ventas' Price Target to $51 From $50, Keeps Outperform Rating MT
Wedbush Raises Price Target on Ventas to $54 Form $52, Keeps Outperform Rating MT
Evercore ISI Adjusts Price Target on Ventas to $50 From $49 MT
Evercore ISI Adjusts Price Target on Ventas to $49 From $50 MT
Evercore ISI Upgrades Ventas to Outperform From In Line, Price Target is $50 MT
Wells Fargo Downgrades Ventas to Equalweight From Overweight, Adjusts Price Target to $46 From $52 MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox... Our Logo
BofA Upgrades Ventas to Buy From Neutral on External Growth Opportunities, Adjusts Price Target to $53 From $48 MT
Mizuho Adjusts Ventas' Price Target to $56 From $53, Maintains Buy Rating MT
RBC Trims Price Target on Ventas to $52 From $53, Keeps Outperform Rating MT
Wells Fargo Adjusts Price Target on Ventas to $47 From $49, Maintains Overweight Rating MT
Wedbush Upgrades Ventas to Outperform From Neutral, Says Showed Determination in Q3 to Return to Growth Track; Raises PT to $51 From $44 MT
ANALYST RECOMMENDATIONS : Amazon, Exxon Mobil, Ford, Walt Disney, PayPal... Our Logo
ANALYST RECOMMENDATIONS : Apple, ADP, Fortinet, General Motors, S&P... Our Logo
BNP Paribas Starts Coverage on Ventas with Outperform Rating, $47 Price Target MT
Wedbush Starts Ventas at Neutral With $44 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
50.26 USD
Average target price
53.78 USD
Spread / Average Target
+7.00%
High Price Target
69 USD
Spread / Highest target
+37.29%
Low Price Target
49 USD
Spread / Lowest Target
-2.51%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Ventas, Inc.

Wells Fargo Securities
JPMorgan Chase
BMO Capital
Scotiabank
Morgan Stanley
Jefferies & Co.
RBC Capital Markets
Evercore ISI
Wedbush
BofA Securities
Mizuho Securities
BNP Paribas Exane
Raymond James
Barclays
Credit Suisse
SMBC Nikko
Baird
KeyBanc Capital Markets
Deutsche Bank Securities
Berenberg Bank
Citigroup
Wolfe Research
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
  1. Stock Market
  2. Equities
  3. VTR Stock
  4. Consensus Ventas, Inc.